Prednimustine, Methotrexate, 5-Fluorouracil, Mitoxantrone and Tamoxifen for Advanced Breast Cancer in Postmenopausal Women: A phase II trials

Acta Oncologica ◽

10.3109/02841868809093531 ◽

1988 ◽

Vol 27 (3) ◽

pp. 235-239 ◽

Author(s):

M. Andersson ◽

H. T. Mouridsen

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Advanced Breast ◽

Phase Ii Trials

Download Full-text

415 Comparison of two Phase II trials evaluating three dosing regimens of fulvestrant in Japanese vs non-Japanese postmenopausal women with advanced breast cancer (FINDER1 and FINDER2)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70441-9 ◽

2010 ◽

Vol 8 (3) ◽

pp. 178

Author(s):

H. Iwata ◽

S. Ohno ◽

Y. Rai ◽

N. Yamamoto ◽

M. Yoshida ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Advanced Breast ◽

Phase Ii Trials ◽

Two Phase ◽

Dosing Regimens

Download Full-text

A Phase II Study (FINDER 2) Comparing Three Dosing Regimens of Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer.

10.1158/0008-5472.sabcs-09-4095 ◽

2009 ◽

Author(s):

K. Pritchard ◽

J. Rolski ◽

Z. Pápai ◽

L. Mauriac ◽

F. Cardoso ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Estrogen Receptor Positive ◽

Dosing Regimens

Download Full-text

Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with hormone responsive advanced breast cancer: no evidence of a pharmacokinetic interaction between exemestane and fulvestrant.

10.1158/0008-5472.sabcs-6131 ◽

2009 ◽

Author(s):

E Mrozek ◽

LJ Schaaf ◽

B Ramaswamy ◽

D Shiels ◽

L Houton ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Trial ◽

Pharmacokinetic Interaction ◽

Advanced Breast

Download Full-text

Survival analysis from two open-label non-randomized phase II trials of trastuzumab (H) combined with docetaxel (T) and platinums (C, cisplatin or carboplatin) (TCH) in women with HER2+ advanced breast cancer (ABC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.642 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 642-642 ◽

Author(s):

D. Slamon ◽

C. H. Yeon ◽

T. Pienkowski ◽

D. Northfelt ◽

W. Eiermann ◽

...

Keyword(s):

Breast Cancer ◽

Survival Analysis ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Phase Ii Trials ◽

Randomized Phase Ii

Download Full-text

Vinorelbine (N)-capecitabine (C) combination in advanced breast cancer (ABC): Long-term results of two multicentric phase II trials

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.673 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 673-673 ◽

Author(s):

M. Ghosn ◽

G. Chahine ◽

J. Kattan ◽

F. Farhat ◽

F. Nasr ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Long Term Results ◽

Phase Ii Trials

Download Full-text

Navelbine (NVB), and fractionated dose doxorubicin (DX) improves first line advanced breast cancer (ABC) chemotherapy. An overview of 3 phase II trials

European Journal of Cancer ◽

10.1016/s0959-8049(97)85224-0 ◽

1997 ◽

Vol 33 ◽

pp. S146 ◽

Author(s):

J. Carmichael ◽

R. Hegg ◽

D. Firat ◽

M. Pawlicki ◽

F. Le Bras ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Phase Ii Trials ◽

Download Full-text

Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial

Annals of Oncology ◽

10.1093/annonc/mdu015 ◽

2014 ◽

Vol 25 (4) ◽

pp. 831-836 ◽

Author(s):

J. Bines ◽

R. Dienstmann ◽

R.M. Obadia ◽

L.G.P. Branco ◽

D.C. Quintella ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Megestrol Acetate

Download Full-text

Weekly Oral Idarubicin in Postmenopausal Women with Advanced Breast Cancer: A Phase II Study

Acta Oncologica ◽

10.3109/02841869009126534 ◽

1990 ◽

Vol 29 (2) ◽

pp. 143-146 ◽

Author(s):

L. Bastholt ◽

M. Dalmark ◽

A. Jakobsen ◽

C. C. Gadeberg ◽

E. Sandberg ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast

Download Full-text

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-1022-9 ◽

2010 ◽

Vol 123 (2) ◽

pp. 453-461 ◽

Author(s):

Kathleen I. Pritchard ◽

Janusz Rolski ◽

Zsuzsanna Papai ◽

Louis Mauriac ◽

Fatima Cardoso ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Dosing Regimens

Download Full-text

Trilostane plus hydrocortisone in postmenopausal women with advanced breast cancer. A phase II study of the Belgian society of medical oncology

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(86)90256-7 ◽

1986 ◽

Vol 22 (6) ◽

pp. 737

Author(s):

M. T'Hooft-Andry ◽

C. Focan ◽

A. Clarysse ◽

J. Michel ◽

J.C. Heuson ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Medical Oncology ◽

Phase Ii Study ◽

Advanced Breast ◽

Belgian Society

Download Full-text